Sponsor Pipeline

Irma Fleming Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07563296 KALM-B: Ketamine-assisted Psychotherapy (KAP) to Lessen Morbidity After Burn Injury PTSD and Trauma-related Symptoms Not Yet Recruiting
Disease Areas
Get alerts when Irma Fleming's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free